Intravenous eradication therapy for bleeding gastroduodenal ulcer associated with Helicobacter pylori infection

Revista Espanola de Enfermedades Digestivas

Volumn 92, Issue 6, 2000, Pages 389-391

  Romero Gómez, Manuel ^a,b   Martinez Delgado C ^a   Grande, L ^a   Otero Fernandez M A ^a   Vargas, J ^a   Castro Fernandez M ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b NONE   (Spain)

Author keywords

Bleeding peptic ulcer; Eradication; Helicobacter pylori; Intravenous triple therapy

Indexed keywords

AMPICILLIN; METRONIDAZOLE; OMEPRAZOLE; RANITIDINE;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; DRUG EFFICACY; ENDOSCOPY; FEMALE; GASTRODUODENAL ULCER; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MALE;

ADULT; AGED; AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INJECTIONS, INTRAVENOUS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PEPTIC ULCER; PROSPECTIVE STUDIES;

EID: 0033942520     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Miño Fungarolas G, Jaramillo JL, Gálvez Calderón C, Carmona Ibáñez C, Reyes López A, De la Mata M. Análisis de una serie general prospectiva de 3.270 hemorragias digestivas altas. Rev Esp Enf Digest 1992;82:7-15.
2. Chinn A, Weckesser EC. Acute hemorrhage from peptic ulceration: an analysis of 322 cases. Ann Intern Med 1951: 339-42.
3. Gisbert JP, Boixeda D, Aller R, De la Serna C, Sanz E, Martín Argila C, et al. Helicobacter pylori y hemorragia digestiva por úlcera péptica duodenal: prevalencia de la infección, eficacia de tres triples terapias y papel de la erradicación en la prevención de la recidiva hemorrágica. Med Clín (Barc) 1999;112:161-5.
4. Romero Gómez M, Vargas J, Utrilla D, Rufo MC, Otero MA, Chávez M, et al. Estudio prospectivo sobre la influencia de la hemorragia ulcerosa en los métodos diagnósticos de infección por H. pylori. Gastroenterol Hepatol 1998;21:267-71.
5. Veenendaal RA, Peña S, Meijer JL, Endtz H, Van der Est MMC, Van Duijn W, et al. Long term serological surveillance after treatment of Helicobacter pylori infection. Gut 1991;32:1291-4.
6. Labenz J, Börsch G. Role of H. pylori erradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55:19-23.
7. Rokkas T, Karamaris A, Mavrogeorgis A. Eradication of H. pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastroeintest Endosc 1995;41:1-4.
8. Gisbert JP, Boixeda D, Martín de Argila C. Nuevas terapias triples de una semana de duración con metronidazol para la erradicación del H. pylori: claritromicina o amoxicilina como segundo antibiótico. Med Clín (Barc) 1998;110:1-5.
9. Cutler AF, Schubert TT. Patient factors affecting H. pylori erradication with triple therapy. Am J Gastroenterol 1993; 88:505-9.
10. Laine R. Comparación aleatoria de dos duraciones distintas de una terapia triple administrada dos veces al día para la erradicación del H. pylori. Aliment Pharmacol Ther 1996; 10:1029-33.
11. Chen CY, Sheu MZ, Lee SC. Intravenous anti-Helicobacter therapy in Helicobacter-positive bleeding peptic ulcer with major stigmata of recent hemorrage: a preliminary report. Gastroenterology 1998;G0361A.
12. Logan RP. Urea breath test in the management of Helicobacter pylori infection. Gut 1998;43:S47-S50.
13. Romero Gómez M, Grande L, Vargas J, Chávez M, Larraona JL, Castilla L, Castro M. ¿De qué factores depende la erradicación de H. pylori mediante una pauta corta de 6 días? Rev Esp Enferrn Dig 1998;90:150 (abstrat 213).
14. Current european concepts in the management of Helicobacter pylori infection. The Maastrich Consensus report. European Helicobacter Group. Gut 1997;41:8-13.
15. Sung JJ, Chung SC, Hosking SW, Chan RC, Ling TK, Yung MY, et al. Mucosal pharmacokinetics and pilot study of short course of parenteral imipenen in the eradication of Helicobacter pylori. J Gastroenterol Hepatol 1995;10:66-9.
16. Adamek RJ, Opferkuch W, Wegener M. Short-term omeprazole oral/amoxicillin intravenous therapy for Helicobacter pylori eradication: a lack of therapeutic effect. Am J Gastroenterol 1994;89:1602-3.
17. Adamek RJ, Wegener M, Labenz J, Freitag M, Opferkuch W, Röld GH. Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy. Asm J Gastroenterol 1994;89:39-42.
18. Adamek RJ, Wegener M. Combined intravenous and oral omeprazole/amoxicillin therapy in patients with Helicobacter pylori-positive acute peptic ulcer bleeding. Am J Gastroenterol 1993;88:1980.
19. Pollak PT. A liquid chromatography assay for the study of serum and gastric juice metronidazole concentrations in the treatment of Helicobacter pylori. Ther Drug Monit 1996; 18:678-87.
20. Van Zanten SJ, Goldie J, Hollingsworth J, Silletti C, Richardson H, Hunt RH. Secretion of intravenous administered antibiotics in gastric juicde: implications for management of Helicobacter pylori. J Clin Pathol 1992;45:225-7.